Results

Total Results: over 10,000 records

Showing results for "cancer".
Users also searched for: colon cancer screening

221. Final Topic Refinement Document - Role of Liquid Biopsy in Detection and Management of Cancer in the Medicare Population (pdf file)
     pcmh.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
     July 29, 2021 - Liquid biopsy has been studied in numerous solid tumor types and in hematologic malignancies. … all solid tumors. … of neoplasia and malignant invasion? … Currently, diagnosis of these cancers (and solid tumors more generally) requires histology or cytology … Human Malignancies.”

222. Final Topic Refinement Document - Role of Liquid Biopsy in Detection and Management of Cancer in the Medicare Population (pdf file)
     healthcare411.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
     July 29, 2021 - Liquid biopsy has been studied in numerous solid tumor types and in hematologic malignancies. … all solid tumors. … of neoplasia and malignant invasion? … Currently, diagnosis of these cancers (and solid tumors more generally) requires histology or cytology … Human Malignancies.”

223. Final Topic Refinement Document - Role of Liquid Biopsy in Detection and Management of Cancer in the Medicare Population (pdf file)
     cahps.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
     July 29, 2021 - Liquid biopsy has been studied in numerous solid tumor types and in hematologic malignancies. … all solid tumors. … of neoplasia and malignant invasion? … Currently, diagnosis of these cancers (and solid tumors more generally) requires histology or cytology … Human Malignancies.”

224. Final Topic Refinement Document - Role of Liquid Biopsy in Detection and Management of Cancer in the Medicare Population (pdf file)
     preventiveservices.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
     July 29, 2021 - Liquid biopsy has been studied in numerous solid tumor types and in hematologic malignancies. … all solid tumors. … of neoplasia and malignant invasion? … Currently, diagnosis of these cancers (and solid tumors more generally) requires histology or cytology … Human Malignancies.”

225. Project Title: Evaluation of Suspicious Skin Lesions Using Non-Invasive Diagnostic Techniques, a Technical Brief (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
     August 23, 2010 - cancer in men and women, accounting for nearly half of all malignancies. … examine how these emerging non-invasive imaging modalities could be used to help diagnose cancerous tumors … whether or not patients have a history of other malignancies. … The rationale for this is the growing recognition of skin cancer as a leading form of second malignancy … Association of nonmelanoma skin cancer with second malignancy. Cancer 2004 January 1;100(1):130-8.

226. Project Title: Evaluation of Suspicious Skin Lesions Using Non-Invasive Diagnostic Techniques, a Technical Brief (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
     August 23, 2010 - cancer in men and women, accounting for nearly half of all malignancies. … examine how these emerging non-invasive imaging modalities could be used to help diagnose cancerous tumors … whether or not patients have a history of other malignancies. … The rationale for this is the growing recognition of skin cancer as a leading form of second malignancy … Association of nonmelanoma skin cancer with second malignancy. Cancer 2004 January 1;100(1):130-8.

227. Screening for Lung Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/mxUT9xnELKAokKcqp92QoW
     August 03, 2020 - Cancer. … What is lung cancer? When cancer starts in the lungs, it is called lung cancer. … This buildup of extra cells can form a tumor or spread to other parts of the body. … of all lung cancers. … /lung-cancer Screening for Lung Cancer Facts About Lung Cancer Facts About Screening for Lung Cancer

228. Imaging for Pretreatment Staging of Small Cell Lung Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/lung-cancer-staging/research-protocol
     December 08, 2014 - cell lung cancer (SCLC) comprises approximately 15% of all lung cancers. 2 The five-year survival rate … Lung cancers are classified based on the size of the main tumor, whether it has locally invaded other … staging and planning 'cancer'/de OR cancer OR tumor* OR tumour* OR mass* OR neoplasm* AND (stage OR … OR tumor* OR tumour* OR mass* OR neoplasm*) AND (stage OR staging OR class*) 9 Pretreatment staging … and planning (cancer[tiab] OR neoplasm[tiab] OR tumor*[tiab] OR tumour*[tiab]) AND (care[tiab] OR

229. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ocULFVqnfy4STqcU2DuPzU
     May 18, 2021 - MAIN OUTCOMES AND MEASURES Colorectal cancer incidence and mortality, test accuracy in detecting cancers … Among all cancers, it is third in incidence and cause of cancer death for both men and women.1 In addition … entails exposure to low-dose ionizing radiation (range, 0.8 to 5.3 mSv), which may increase the risk of malignancy … Interval cancers in a population-based screening program for colorectal cancer in Catalonia, Spain. … Extracolonic tumors of the gastrointestinal tract detected incidentally at screening CT colonography.

230. Cancer
     hcup-us.ahrq.gov/reports/factsandfigures/figures/2006/2006_5_3c.jsp
     January 01, 2006 - Cancer Most Frequent Hospitalizations with a Principal Diagnosis of Cancer by Sex, 2006 … CANCER CCS DIAGNOSIS DISCHARGES IN THOUSANDS Male Female Cancer of bronchus, lung … 107 93 Cancer of colon 65 70 Cancer of breast 1 119 Cancer of prostate … 30 24 Cancer of kidney and renal pelvis 33 21 Cancer of uterus 0 44 Cancer … of bladder 32 11 Cancer of head and neck 30 12 Cancer of ovary 0 40 Cancer

231. Cancer
     hcup-us.ahrq.gov/reports/factsandfigures/figures/2006/2006_5_3b.jsp
     January 01, 2006 - Cancer Discharge Prevalence for Cancer by Region, 2006 REGION DISCHARGES PER 100,000

232. Evidence Summary: Pancreatic Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/pancreatic-cancer-screening
     August 06, 2019 - , intraductal papillary mucinous neoplasm, and mucinous cystic neoplasm. … (n = 5), pancreatic intraepithelial neoplasia (n = 13), or both intraductal papillary mucinous neoplasm … and pancreatic intraepithelial neoplasia (n = 20). … Detection of pancreatic adenocarcinoma precursor lesions (intraductal papillary mucinous neoplasms or … pancreatic intraepithelial neoplasia) was also observed.

233. Development of the CAHPS Cancer Care Survey | Agency for Healthcare Research and Quality
     www.ahrq.gov/cahps/surveys-guidance/cancer/develop-cancer-surveys.html
     March 01, 2017 - Development of the CAHPS Cancer Care Survey The CAHPS ® Cancer Care Survey was developed and … It was sponsored by AHRQ’s CAHPS program and the Outcomes Research Branch of the National Cancer Institute … AIR and Mayo Clinic began by developing a conceptual framework for understanding patient-centered cancer … -item survey that included 41 questions designed to measure patient experiences in eight domains of cancer … They also conducted testing of the proposed measures with patients who had received cancer treatment.

234. Management of Renal Masses and Localized Renal Cancer | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/renal-cancer/research
     December 01, 2019 - In preoperative composite models of patient and tumor characteristics, male sex and increased tumor size … Cancer-specific survival was excellent among all management strategies with a median 5-year cancer-specific … Conclusions No composite model reliably predicts malignancy, although tumor size and male sex are highly … associated with malignancy. … Most patients with non-diagnostic biopsies who proceed to surgery are found to have malignancy.

235. Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_clinician.pdf
     July 01, 2017 - Renal cell carcinoma accounts for more than 94 percent of kidney malignancies. … treatment for patients with clinical stage T1a tumors (≤4 cm in diameter) and T1b tumors (4–7 cm) … (9,401) A positive relationship between tumor size and malignancy risk was found. 1.326 (1.220 to … and malignancy risk was found. … potential of tumors treated with RN.

236. Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/renal-cancer_clinician.pdf
     July 01, 2017 - Renal cell carcinoma accounts for more than 94 percent of kidney malignancies. … treatment for patients with clinical stage T1a tumors (≤4 cm in diameter) and T1b tumors (4–7 cm) … (9,401) A positive relationship between tumor size and malignancy risk was found. 1.326 (1.220 to … and malignancy risk was found. … potential of tumors treated with RN.

237. Methods Research Report - Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/survival-quality_research.pdf
     April 01, 2013 - "[Mesh] OR (breast AND (cancer OR cancers OR neoplasms OR carcinoma*)) AND ("progression-free survival … "[Mesh] OR (breast AND (cancer OR cancers OR neoplasms OR carcinoma*)) AND ("progression-free survival … "[Mesh] OR (breast AND (cancer OR cancers OR neoplasms OR carcinoma*)) AND ("progression-free survival … "[Mesh] OR ((ovary OR ovarian) AND (cancer OR cancers OR neoplasms OR carcinoma*))) AND ("progression-free … ") AND (cancer OR cancers OR carcinoma* OR neoplasms))) AND ("progression-free survival" OR "time to

238. Methods Research Report - Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/survival-quality_research.pdf
     April 01, 2013 - "[Mesh] OR (breast AND (cancer OR cancers OR neoplasms OR carcinoma*)) AND ("progression-free survival … "[Mesh] OR (breast AND (cancer OR cancers OR neoplasms OR carcinoma*)) AND ("progression-free survival … "[Mesh] OR (breast AND (cancer OR cancers OR neoplasms OR carcinoma*)) AND ("progression-free survival … "[Mesh] OR ((ovary OR ovarian) AND (cancer OR cancers OR neoplasms OR carcinoma*))) AND ("progression-free … ") AND (cancer OR cancers OR carcinoma* OR neoplasms))) AND ("progression-free survival" OR "time to

239. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - How do tumor characteristics affect outcomes? … volume to identify low-, intermediate-, and high risk tumors. … OR "prostate cancer" AND Limits: Meta-Analysis OR prostatic neoplasms OR "prostate cancer" AND … OR "prostate cancer" AND prostate-specific antigen OR "tumor characteristics" OR "tumor volume" OR … volume to identify low-, intermediate-, and high risk tumors.

240. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - How do tumor characteristics affect outcomes? … volume to identify low-, intermediate-, and high risk tumors. … OR "prostate cancer" AND Limits: Meta-Analysis OR prostatic neoplasms OR "prostate cancer" AND … OR "prostate cancer" AND prostate-specific antigen OR "tumor characteristics" OR "tumor volume" OR … volume to identify low-, intermediate-, and high risk tumors.